Effects of a clinical pathway on antibiotic use in patients with community-acquired pneumonia: a multi-site study in China

摘要

BackgroundCommunity-acquired pneumonia (CAP) is a common condition with high mortality, morbidity and healthcare costs. This study aimed to determine whether clinical pathway (CP) implementation in different hospitals in China increased antibiotic compliance with the national CP in inpatients with CAP.